Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 781 results for "Shionogi"

Should Gilead Sciences, inc. Fear This New Competitor Drug?
Motley Fool

Should Gilead Sciences, inc. Fear This New Competitor Drug?

According to ViiV Healthcare -- GlaxoSmithKline ( NYSE: GSK ) , Pfizer ( NYSE: PFE ) , and Shionogi 's HIV drug consortium -- one in three Americans fails to take their HIV medication as prescribed. That means hundreds of thousands of patients ... Motley Fool, 3 days ago

2 images for "Shionogi"

4 Traders, 2 weeks ago
Examiner.com, 3 weeks ago

Research and Markets: Global Postmenopausal Vaginal Atrophy Drugs Market 2014-2018 with Actavis, Novo Nordisk, Pfizer & Shionogi & Co. Dominating

The Global PVA Drugs market can be divided into two segments: Topical Estrogen and Systemic Estrogen. To calculate the market size, the report considers the revenue generated from the sales of various drugs (creams, tablets, ...
 Morningstar.com1 month ago Global Postmenopausal Vaginal Atrophy Drugs Market 2014-2018 with Actavis, Novo Nordisk, Pfizer & Shionogi & Co. Dominating  Individual.com1 month ago Global PVA Drugs market will grow at 7.1% CAGR over the period 2013-2018.  TransWorldNews2 weeks ago RESEARCH AND MARKETS : Global Postmenopausal Vaginal Atrophy Drugs Market 2014-2018 with Actavis, Novo Nordisk, Pfizer & Shionogi & Co. Dominating  4 Traders1 month ago
[x]  

SHIONOGI & CO LTD (0001281721) (Filed by)

 SEC Filings1 month ago SHIONOGI & CO LTD (0001281721)  SEC1 month ago

Shionogi Annual Report 2014

 Noodls2 hours ago SHIONOGI : Transfers All Assets in Ezose Sciences, a US Subsideary Providing Glycan Analytical Services, to Sumitomo Bakelite Co., Ltd.  4 Traders4 weeks ago Shionogi Transfers All Assets in Ezose Sciences, a US Subsideary Providing Glycan Analytical Services, to Sumitomo Bakelite Co., Ltd.  Noodls4 weeks ago

Shionogi : ViiV Healthcare Receives FDA approval for Triumeq a Single-pill Regimen Containing the Integrase Inhibitor 'Dolutegravir'

Release date- 25082014 - Osaka, Japan , - Shionogi & Co., Ltd. (Head Office: Osaka ; President & CEO: Isao Teshirogi , Ph.D.; hereafter ' Shionogi ') today announced that the UK -based company, ViiV Healthcare Ltd. (Head Office: London ; Chief ...
 4 Traders4 days ago ViiV Healthcare Receives FDA approval for Triumeq®,a Single-pill Regimen Containing the Integrase Inhibitor Dolutegravir  Noodls4 days ago Shionogi to Determine the Contents of Stock Options as Compensation (Stock Acquisition Rights)  HispanicBusiness.com1 month ago Triumeq US Approval  Noodls3 days ago
[x]  
Stock Nod

SHIONOGI : Pragma Pharmaceuticals Releases Moxatag

Pragma Pharmaceuticals is re-launching Moxatag 775 mg (amoxicillin extended-release tablets). In its release on Aug. 15 , the Company said that Pragma acquired Moxatag from Shionogi in March 2014 and has been working to make the product available ...
 4 Traders1 week ago Fera to roll out Moxatag authorized generic  Chain Drug Review3 days ago CORRECTING and REPLACING Pragma Pharmaceuticals Announces Re-Launch of Moxatag®  Stock Nod1 week ago Pragma Pharmaceuticals Releases Moxatag  Individual.com1 week ago
[x]  

StructureActivity Relationship Studies and Discovery of a Potent Transient Receptor Potential Vanilloid (TRPV1) Antagonist 4-[3-Chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517

† Discovery Research, Purdue Pharma LP, 6 Cedar Brook Drive, Cranbury, New Jersey 08512, United States‡ Shionogi Research Laboratories, Shionogi & Co., Ltd., 3-1-1 Futaba-chow, Toyonaka,
 Journal of Medicinal Chemistry4 weeks ago

SHIONOGI : ViiV Healthcare Assigned Patent

By Targeted News Service ALEXANDRIA, Va. , July 17 -- ViiV Healthcare, Research Triangle Park, North Carolina , and Shionogi & Co. , Osaka, Japan , have been assigned a patent (8,778,943) developed by four co-inventors for "substituted ...
 4 Traders1 month ago U.S. Patents Awarded to Inventors in North Carolina (July 17)  TMC Net1 month ago

Is GlaxoSmithKline A Solid Long-Term Investment?

Summary The Chinese issues have caused the stock price to fall and we believe this fall has created a buying opportunity. Sales growth for Promacta remains strong and the addition of another indication will allow the company to further grow its ...
 Seeking Alpha8 hours ago

Plethora Solutions : Targets Fundraise As Losses Widen

LONDON ( Alliance News ) - Plethora Solutions Holdings PLC Friday said it hopes to raise around GBP15.9 million to fund the USD25 million acquisition of the royalty rights in PSD502 thus consolidating the group's intellectual property rights, as its ...
 4 Traders12 hours ago INTERIM RESULTS  TrustNet12 hours ago Plethora Solutions Holdings PLC Fundraising and Notice of General..  ADVFN UK12 hours ago Fundraising and Notice of General Meeting  TrustNet13 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less